Viridian Therapeutics is a biopharmaceutical company developing medicines for serious and rare diseases, with a focus on thyroid eye disease. It last closed at $29.96 on Nov 20, down 4.71% on the day. The next earnings report for VRDN is expected around Thu, Feb 25, 2027. Over its last 8 reports the stock moved an average of 9.7% the session after earnings. Over the last 12 months VRDN insiders bought $20.0M of stock on the open market and sold $419K, according to SEC Form 4 filings.
AI Auto Pilots
Is VRDN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VRDN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on VRDNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
VRDN · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought
The stock is 6% above its 20 day and 21% above its 50 day average. It is 28% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 64), near overbought. The nearest support is the Pivot S1 at $29.30, and the nearest resistance the Pivot at $30.53.
Short trendBullish
Long trendBullish
MomentumImproving
StretchNear overbought
VolatilityHigh, 4.6%/day
Key levels
$34.2952 week high+14.5%
$31.63Swing high (Nov 11)+5.6%
$31.18Pivot R1+4.1%
$30.53Pivot+1.9%
$29.96Last close
$29.30Pivot S1−2.2%
$29.25Swing low (Nov 17)−2.4%
$28.1420 day average−6.1%
$23.5350 day average−21.5%
$22.46100 day average−25.0%
$21.52200 day average−28.2%
$13.1852 week low−56.0%
Indicators
RSI (14)
64.01
Strong, overbought above 70
Neutral
MACD
2.23
Below its signal line
Bearish
Stochastic
84.3
Near the top of its range
Overbought
ADX (14)
53.0
Strong uptrend
Williams %R
-24.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
65.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+5.2%
Change over 10 sessions
Bullish
ATR (14)
$1.37
Typical daily range, 4.6% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, nearing overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 9.1%/day
Key levels
$34.2952 week high+14.5%
$31.63Swing high (Nov 11)+5.6%
$31.18Pivot R1+4.1%
$30.53Pivot+1.9%
$29.96Last close
$29.30Pivot S1−2.2%
$29.25Swing low (Nov 17)−2.4%
$28.1420 day average−6.1%
$23.5350 day average−21.5%
$22.46100 day average−25.0%
$21.52200 day average−28.2%
$13.1852 week low−56.0%
Indicators
RSI (14)
66.91
Strong, overbought above 70
Neutral
MACD
1.78
Above its signal line
Bullish
Stochastic
90.5
Near the top of its range
Overbought
ADX (14)
22.3
Weak trend
Williams %R
-12.6
Oversold below −80, overbought above −20
Overbought
CCI (20)
203.5
Oversold below −100, overbought above 100
Overbought
Rate of change
+41.0%
Change over 10 sessions
Bullish
ATR (14)
$2.72
Typical daily range, 9.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for VRDN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VRDN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow VRDN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for VRDNHow many large options trades hit VRDN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in VRDN in the last 90 days.
From SEC Form 4 filings by VRDN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VRDN is in one of them and how their past VRDN trades turned out.
Viridian Therapeutics is a biopharmaceutical company based in Waltham, Massachusetts. It develops medicines for serious and rare diseases, with its main focus on thyroid eye disease, a rare autoimmune condition that affects the eyes. Its pipeline includes antibody treatments that target the IGF-1R pathway and engineered FcRn inhibitors being studied for several autoimmune disorders. The company is preparing to sell its medicines to patients, physicians and insurers if they are approved.